BACKGROUND & AIMS: In healthy individuals, interactions between intestinal epithelial cells and lamina propria lymphocytes give rise to a population of CD8(+) T cells with suppressor functions (Ts cells). Disruption of Ts cell activities can lead to mucosal inflammation. We investigated what factors were required for expansion of the Ts cell population or loss of their activity in patients with Crohn's disease (CD). METHODS: We developed a method to generate Ts cell lines from freshly isolated lamina propria lymphocytes from patients with ulcerative colitis (UC), patients with CD, or healthy individuals (controls). Cells were stimulated with a monoclonal antibody against CD3, interleukin (IL)-7, and IL-15. After 14 days in culture, CD8(+)T cells were purified and cultured with IL-7 and IL-15. The resulting Ts cells were analyzed for suppressor activity, expression of surface markers, and cytokine secretion profiles. RNA was isolated from the 3 groups of Ts cells and used in microarray analyses. RESULTS: Ts cells from patients with UC and controls suppressed proliferation of CD4(+) T cells; the suppression required cell contact. In contrast, Ts cells from patients with CD had a reduced capacity to suppress CD4(+) T-cell proliferation. The difference in suppressive ability was not associated with surface or intracytoplasmic markers or secretion of cytokines. Microarray analysis identified changes in expression of genes regulated by transforming growth factor (TGF)-β that were associated with the suppressive abilities of Ts cells. We found that TGF-β or supernatants from Ts cells of patients with CD reduced the suppressor activity of control Ts cells. CONCLUSIONS: Ts cells isolated from patients with CD have a reduced ability to suppress proliferation of CD4(+)T cells compared with control Ts cells. TGF-β signaling reduces the suppressor activity of Ts cells.
BACKGROUND & AIMS: In healthy individuals, interactions between intestinal epithelial cells and lamina propria lymphocytes give rise to a population of CD8(+) T cells with suppressor functions (Ts cells). Disruption of Ts cell activities can lead to mucosal inflammation. We investigated what factors were required for expansion of the Ts cell population or loss of their activity in patients with Crohn's disease (CD). METHODS: We developed a method to generate Ts cell lines from freshly isolated lamina propria lymphocytes from patients with ulcerative colitis (UC), patients with CD, or healthy individuals (controls). Cells were stimulated with a monoclonal antibody against CD3, interleukin (IL)-7, and IL-15. After 14 days in culture, CD8(+)T cells were purified and cultured with IL-7 and IL-15. The resulting Ts cells were analyzed for suppressor activity, expression of surface markers, and cytokine secretion profiles. RNA was isolated from the 3 groups of Ts cells and used in microarray analyses. RESULTS: Ts cells from patients with UC and controls suppressed proliferation of CD4(+) T cells; the suppression required cell contact. In contrast, Ts cells from patients with CD had a reduced capacity to suppress CD4(+) T-cell proliferation. The difference in suppressive ability was not associated with surface or intracytoplasmic markers or secretion of cytokines. Microarray analysis identified changes in expression of genes regulated by transforming growth factor (TGF)-β that were associated with the suppressive abilities of Ts cells. We found that TGF-β or supernatants from Ts cells of patients with CD reduced the suppressor activity of control Ts cells. CONCLUSIONS: Ts cells isolated from patients with CD have a reduced ability to suppress proliferation of CD4(+)T cells compared with control Ts cells. TGF-β signaling reduces the suppressor activity of Ts cells.
Authors: John P Burke; Jurgen J Mulsow; Conor O'Keane; Neil G Docherty; R William G Watson; P Ronan O'Connell Journal: Am J Gastroenterol Date: 2006-12-11 Impact factor: 10.864
Authors: Alexandra Zhernakova; Eleanora M Festen; Lude Franke; Gosia Trynka; Cleo C van Diemen; Alienke J Monsuur; Marianna Bevova; Rian M Nijmeijer; Ruben van 't Slot; Roel Heijmans; H Marike Boezen; David A van Heel; Adriaan A van Bodegraven; Pieter C F Stokkers; Cisca Wijmenga; J Bart A Crusius; Rinse K Weersma Journal: Am J Hum Genet Date: 2008-04-24 Impact factor: 11.025
Authors: Irina Fernandez; Robert Zeiser; Holger Karsunky; Neeraja Kambham; Andreas Beilhack; Kalle Soderstrom; Robert S Negrin; Edgar Engleman Journal: J Immunol Date: 2007-09-01 Impact factor: 5.422
Authors: Julia Seiderer; Ira Elben; Julia Diegelmann; Jürgen Glas; Johannes Stallhofer; Cornelia Tillack; Simone Pfennig; Matthias Jürgens; Silke Schmechel; Astrid Konrad; Burkhard Göke; Thomas Ochsenkühn; Bertram Müller-Myhsok; Peter Lohse; Stephan Brand Journal: Inflamm Bowel Dis Date: 2008-04 Impact factor: 5.325
Authors: Johnson Ho; Courtney C Kurtz; Makoto Naganuma; Peter B Ernst; Fabio Cominelli; Jesús Rivera-Nieves Journal: J Immunol Date: 2008-02-15 Impact factor: 5.422
Authors: Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman Journal: Nature Date: 2008-03-26 Impact factor: 49.962
Authors: D R Mathern; L E Laitman; Z Hovhannisyan; D Dunkin; S Farsio; T J Malik; G Roda; A Chitre; A C Iuga; G Yeretssian; M C Berin; S Dahan Journal: Mucosal Immunol Date: 2014-01-15 Impact factor: 7.313
Authors: Z Meng; X Ma; J Du; X Wang; M He; Y Gu; J Zhang; W Han; Z Fang; X Gan; C Van Ness; X Fu; D E Schones; R Xu; W Huang Journal: Oncogene Date: 2016-11-07 Impact factor: 9.867
Authors: Renata Curciarello; Karina E Canziani; Ileana Salto; Emanuel Barbiera Romero; Andrés Rocca; Ivan Doldan; Emmanuel Peton; Santiago Brayer; Alicia M Sambuelli; Silvina Goncalves; Pablo Tirado; Gustavo J Correa; Martín Yantorno; Laura Garbi; Guillermo H Docena; María de Los Ángeles Serradell; Cecilia I Muglia Journal: Front Pharmacol Date: 2021-04-15 Impact factor: 5.810
Authors: G Roda; X Jianyu; M S Park; L DeMarte; Z Hovhannisyan; R Couri; C P Stanners; G Yeretssian; L Mayer Journal: Mucosal Immunol Date: 2013-10-09 Impact factor: 7.313